The State of Scientists' Salaries

Getty Images Tis a good time to be a life scientist. Thanks to increases in the National Institutes of Health budget, a flood of defense spending, and a gradual warming in the biotechnology and pharmaceutical industries, experienced investigators are in great demand. For senior US researchers, the benefits of the federal largesse appear in 2003 paychecks, according to The Scientist's latest salary survey. The average senior researcher, who holds a PhD and leads a lab, will earn $73,351(US) th

Written bySam Jaffe
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Tis a good time to be a life scientist. Thanks to increases in the National Institutes of Health budget, a flood of defense spending, and a gradual warming in the biotechnology and pharmaceutical industries, experienced investigators are in great demand.

For senior US researchers, the benefits of the federal largesse appear in 2003 paychecks, according to The Scientist's latest salary survey. The average senior researcher, who holds a PhD and leads a lab, will earn $73,351(US) this year, a 7.3% increase over the $68,000 (US) average in 2002. Intermediate researchers' salaries rose 4.7%, from $48,000 to $50,250. The Consumer Price Index (CPI) rose only 2.1% in the 12-month period ending in July.

But researchers across the northern US border and across the Atlantic may not be popping champagne corks. Senior UK scientists, who consistently receive lower salaries than their US counterparts,1 saw their wages increase by only 1.7%, from £28,000 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies